Astera Labs Shares Tumble Amid Amazon Deal Skepticism Despite Earnings Beat

Astera Labs' shares experienced a significant decline on Wednesday, despite the company reporting stronger-than-expected fourth-quarter earnings. The negative market reaction stemmed primarily from investor skepticism regarding the implications of its substantial $6.5 billion chip deal with Amazon. Investors questioned the long-term benefits and potential drawbacks of this major supply agreement. This widespread doubt overshadowed the positive financial results, leading to a notable sell-off. The market's focus clearly shifted from short-term performance to the strategic implications of the Amazon partnership.